SE8103107L - Forfarande for framstellning av 4a-aryl-oktahydro-1h-2-pyrindiner - Google Patents

Forfarande for framstellning av 4a-aryl-oktahydro-1h-2-pyrindiner

Info

Publication number
SE8103107L
SE8103107L SE8103107A SE8103107A SE8103107L SE 8103107 L SE8103107 L SE 8103107L SE 8103107 A SE8103107 A SE 8103107A SE 8103107 A SE8103107 A SE 8103107A SE 8103107 L SE8103107 L SE 8103107L
Authority
SE
Sweden
Prior art keywords
compound
preparation
pyrindines
octahydro
aryl
Prior art date
Application number
SE8103107A
Other languages
English (en)
Inventor
D M Zimmerman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE8103107L publication Critical patent/SE8103107L/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/757Unsaturated compounds containing a keto groups being part of a ring containing —CHO groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Claims (1)

1. Patentkrav Forfarande for framstLllning am an ci 6rening med den all- manna formeln: dar 01 betecknar fenyletyl eller CH2R3, och R3 betecknar 03-C6-cykloalkyl; och R2 betecknar vate, hydroxi eller C1-C3-alkoxi; cant ogiftiga farmaceutiskt godtagbara syraadditionssalte, ctrav, kannetecknat am alt en f6rening med den allmnna formeln: dar R2 bar ovan angivna betydelse, omsRttes med ett acyleringsmedel, varefter den erhallna fOreningen reduceras; varefter eventuellt, nar 02 betecknar C1-C3-alkox, Can erhallna foreningen avetras till bildning am en forening med formeln I, dar R2 betecknar hydroxi.
SE8103107A 1976-11-02 1981-05-18 Forfarande for framstellning av 4a-aryl-oktahydro-1h-2-pyrindiner SE8103107L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73795876A 1976-11-02 1976-11-02

Publications (1)

Publication Number Publication Date
SE8103107L true SE8103107L (sv) 1981-05-18

Family

ID=24965981

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7712218A SE7712218L (sv) 1976-11-02 1977-10-28 Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE8103107A SE8103107L (sv) 1976-11-02 1981-05-18 Forfarande for framstellning av 4a-aryl-oktahydro-1h-2-pyrindiner
SE8103106A SE8103106L (sv) 1976-11-02 1981-05-18 Forfarande for framstellning av 4a-aryl-oktahydro-1h-2-pyrindiner

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7712218A SE7712218L (sv) 1976-11-02 1977-10-28 Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8103106A SE8103106L (sv) 1976-11-02 1981-05-18 Forfarande for framstellning av 4a-aryl-oktahydro-1h-2-pyrindiner

Country Status (26)

Country Link
JP (1) JPS5356669A (sv)
AR (1) AR223454A1 (sv)
AT (1) ATA782177A (sv)
AU (1) AU513679B2 (sv)
BE (1) BE860314A (sv)
CA (1) CA1100136A (sv)
CS (1) CS211380B2 (sv)
DD (1) DD133795A5 (sv)
DE (1) DE2748466A1 (sv)
DK (1) DK485277A (sv)
ES (3) ES463783A1 (sv)
FR (1) FR2369267A1 (sv)
GB (1) GB1590155A (sv)
GR (1) GR70053B (sv)
HU (1) HU176231B (sv)
IE (1) IE45901B1 (sv)
IL (1) IL53236A0 (sv)
NL (1) NL7712053A (sv)
NZ (1) NZ185539A (sv)
PH (1) PH12590A (sv)
PL (3) PL109690B1 (sv)
PT (1) PT67194B (sv)
RO (3) RO78300A (sv)
SE (3) SE7712218L (sv)
SU (3) SU812174A3 (sv)
ZA (1) ZA776497B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ189230A (en) * 1977-12-27 1981-05-15 Lilly Co Eli Trans-4a-aryl-2-substituted-octahydro-1h-2-pyrindines
US4277608A (en) * 1979-06-21 1981-07-07 Eli Lilly And Company Method of preparing 4a-arylhexahydro-1H-2-pyrindines and 4a-aryloctahydroisoquinolines
US4236009A (en) * 1979-06-21 1980-11-25 Eli Lilly And Company Method of preparing 4A-arylhexahydro-1H-2-pyrindines and 4A-aryloctahydroisoquinolines
ZA9510829B (en) * 1994-12-23 1996-07-03 Smithkline Beecham Corp 3,3-(disubstituted)cyclohexan-1-one monomers and related compounds
WO2011140425A1 (en) 2010-05-06 2011-11-10 Vertex Pharmaceuticals Incorporated Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
PT2670752E (pt) 2011-02-02 2016-06-14 Vertex Pharma Piperidinamidas pirrolopirazina-espirocíclicas como moduladores de canais iónicos
WO2012112743A1 (en) 2011-02-18 2012-08-23 Vertex Pharmaceuticals Incorporated Chroman - spirocyclic piperidine amides as modulators of ion channels
MX347982B (es) 2011-03-14 2017-05-22 Vertex Pharma Morfolina-piperidina espirociclica-amidas como moduladores de canales ionicos.

Also Published As

Publication number Publication date
AR223454A1 (es) 1981-08-31
JPS5356669A (en) 1978-05-23
ATA782177A (de) 1981-10-15
PL108466B1 (en) 1980-04-30
IE45901L (en) 1978-05-02
CS211380B2 (en) 1982-02-26
PL201885A1 (pl) 1978-12-04
DE2748466A1 (de) 1978-05-03
BE860314A (fr) 1978-04-28
SE7712218L (sv) 1978-05-03
SU845777A3 (ru) 1981-07-07
HU176231B (en) 1981-01-28
PT67194A (en) 1977-11-01
RO78300A (ro) 1982-04-12
ES472276A1 (es) 1979-10-01
SU812174A3 (ru) 1981-03-07
NL7712053A (nl) 1978-05-05
GB1590155A (en) 1981-05-28
PL108610B1 (en) 1980-04-30
RO77935A (ro) 1981-12-25
FR2369267A1 (fr) 1978-05-26
ZA776497B (en) 1979-06-27
ES463784A1 (es) 1978-06-16
NZ185539A (en) 1979-12-11
IL53236A0 (en) 1977-12-30
IE45901B1 (en) 1982-12-29
PT67194B (en) 1979-03-23
AU3023577A (en) 1979-05-10
SU913941A3 (en) 1982-03-15
DK485277A (da) 1978-05-03
RO72900A (ro) 1981-11-04
SE8103106L (sv) 1981-05-18
GR70053B (sv) 1982-07-26
ES463783A1 (es) 1979-07-16
FR2369267B1 (sv) 1980-05-16
PL109690B1 (en) 1980-06-30
AU513679B2 (en) 1980-12-18
CA1100136A (en) 1981-04-28
DD133795A5 (de) 1979-01-24
PH12590A (en) 1979-06-27

Similar Documents

Publication Publication Date Title
IE42216L (en) Benzomorphane derivatives
PT87163A (pt) Process for preparing 1-phenyl-3-naphthalenyloxipropanamines
GR69233B (sv)
IE41528L (en) Furfuryl-benzomorphane derivatives.
ES405983A1 (es) Procedimiento para la preparacion de derivados de fenileti-lamina fluoralcohilados.
SE8103107L (sv) Forfarande for framstellning av 4a-aryl-oktahydro-1h-2-pyrindiner
SE8305918L (sv) Mellanprodukter for framstellning av bensimidazolderivat
ES474232A1 (es) Un metodo para producir 2,6-diaminonebularinas
ES454063A1 (es) Un procedimiento para la preparacion de nuevos derivados delalcohol bencilico.
BR8105437A (pt) Processo para a preparacao de derivados de azolilaquila, composicoes fungicidas, processos para combater fungos e para a preparacao das composicoes
IE43931L (en) Homophthalimides
ES424309A1 (es) Procedimiento para la preparacion de n-(heteroarilmetil)-7 -acil-6,14-endoetenotetrahidronororipavinas y -tebainas.
ES274329A1 (es) Procedimiento para la preparacion de nuevos compuestos de 1,5-benzodioxepano
IE790924L (en) 1,3-benzodioxin derivatives
IE43121L (en) Alkynes.
ES440135A1 (es) Procedimiento para producir s-inosilcisteina.
US4027030A (en) Certain thiazole-carboxamides and their pharmaceutical utility
ES428442A1 (es) Un procedimiento para la preparacion de derivados de 1, 2, 3, 4-tetrahidroisoquinoleina.
GB1085075A (en) 8-aza-steroid derivatives
GB986644A (en) Novel derivatives of salicylic acid and preparations thereof
ES401174A1 (es) Procedimiento para la preparacion de nuevos esteres alcohi-licos del acido tiolcarbamidico basicamente sustituidos.
JPS525730A (en) Process for preparation of 1,3,5-tri-substituted derivatives
SE7713864L (sv) Nortropinkarbazatderivat och forfarande for framstellning av dem
KR860008142A (ko) 피라졸리디늄 일리드의 제조방법
ES447349A1 (es) Un procedimiento para la preparacion de nuevos derivados delacido 8-azaprostanoico.